NAGE News & Events

Niagen Bioscience (NAGE) announced OneSpaWorld (OSW) as the newest Niagen Plus provider, engaged to offer pharmaceutical grade Niagen IV at over 80 Medi-Spa clinics onboard high-end cruise ships. Marking Niagen Bioscience's first cruise ship clinic partnership, this collaboration brings Niagen IV to guests at sea. Rob Fried, CEO of Niagen Bioscience, commented, "OneSpaWorld opens a new premium channel at sea, strengthens our rapidly expanding Niagen Plus clinic footprint, and supports our strategy to scale Niagen IV and injections outside of the U.S."

Niagen Bioscience announced that its board of directors has authorized an increase to the company's previously disclosed share repurchase program, raising the total authorization from $10M to $20M of the company's outstanding common stock. Through March 17, the company has repurchased approximately $2.6M of its common stock under the share repurchase program.